Questcor reported Acthar paid prescriptions for September of 105-110 in Nephrotic Syndrome and 400-410 in Multiple Sclerosis. This compares to 119 and 508, respectively, in August. Questcor said patients with "serious, difficult-to-treat medical conditions continue to have access to Acthar, through commercial insurance, Medicare, Medicaid and other government programs as well as through our free drug program."
The Federal Reserve on Wednesday said it would keep buying $85 billion in bonds per month and gave no explicit …